Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Last updated:
2026-08-15
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND

Intervention/treatment:
TRALOKINUMAB (CAT-354)
Medical condition:
ATOPIC DERMATITIS
Protocol code:
LP0162-1337
Control number:
218249
Status:
Closed
Approved:
August 03, 2018
Date Completed:
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT03587805
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
12 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Clinical Disclosure
Organization
LEO Pharma A/S
Phone:
+45 44945888
Sponsor
LEO PHARMA AS

Locations

Alberta

LEO Pharma Investigational Site
Calgary, Alberta, T2J 7E1
LEO Pharma Investigational Site
Calgary, Alberta, T3E 0B2
LEO Pharma Investigational Site
Edmonton, Alberta, T5K 1X3
LEO Pharma Investigational Site
Edmonton, Alberta, T6G 1C3
LEO Pharma Investigational Site
Edmonton, Alberta, T6G 2B7

British Columbia

LEO Pharma Investigational Site
Surrey, British Columbia, V3R 6A7
LEO Pharma Investigational Site
Surrey, British Columbia, V3V 0C6
LEO Pharma Investigational Site
Vancouver, British Columbia, V5Z 4E8
LEO Pharma Investigational Site
Vancouver, British Columbia, V6H 4E1

Manitoba

LEO Pharma Investigational Site
Winnipeg, Manitoba, R3C 0N2
LEO Pharma Investigational Site
Winnipeg, Manitoba, R3M 3Z4

New Brunswick

LEO Pharma Investigational Site
Bathurst, New Brunswick, E2A 4Z9
LEO Pharma Investigational Site
Fredericton, New Brunswick, E3B 1G9

Newfoundland and Labrador

LEO Pharma Investigational Site
St. John's, Newfoundland and Labrador, A1A 4Y3

Nova Scotia

LEO Pharma Investigational Site
Halifax, Nova Scotia, B3H 1Z2

Ontario

LEO Pharma Investigational Site
Ajax, Ontario, L1S 7K8
LEO Pharma Investigational Site
Etobicoke, Ontario, M8X 1Y9
LEO Pharma Investigational Site
Hamilton, Ontario, L8S 1G5
LEO Pharma Investigational Site
London, Ontario, N6A 3H7
LEO Pharma Investigational Site
London, Ontario, N6H 5L5
LEO Pharma Investigational Site
Markham, Ontario, L3P 1X3
LEO Pharma Investigational Site
Mississauga, Ontario, L5H 1G9
LEO Pharma Investigational Site
North Bay, Ontario, P1B 3Z7
LEO Pharma Investigational Site
Oakville, Ontario, L6J 7W5
LEO Pharma Investigational Site
Ottawa, Ontario, K2C 3N2
LEO Pharma Investigational Site
Peterborough, Ontario, K9J 5K2
LEO Pharma Investigational Site
Richmond Hill, Ontario, L4B 1A5
LEO Pharma Investigational Site
Richmond Hill, Ontario, L4C 9M7
LEO Pharma Investigational Site
Toronto, Ontario, M3B 3S6
LEO Pharma Investigational Site
Toronto, Ontario, M4W 2N2
LEO Pharma Investigational Site
Toronto, Ontario, M5A 3R6
LEO Pharma Investigational Site
Waterloo, Ontario, N2J 1C4
LEO Pharma Investigational Site
Windsor, Ontario, N8W 1E6
LEO Pharma Investigational Site
Windsor, Ontario, N8X 2G1

Quebec

LEO Pharma Investigational Site
Montreal, Quebec, H3H 1V4
LEO Pharma Investigational Site
Québec, Quebec, G1V 4X7
LEO Pharma Investigational Site
Verdun, Quebec, H4G 3E7

Saskatchewan

LEO Pharma Investigational Site
Saskatoon, Saskatchewan, S7K 0H6

Results

See the results from the trial NCT03587805. This is an external link. The information is not authorized by the Government of Canada.

Date posted:
Did you find what you were looking for?